Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex

Synapse

Volumn 38, Issue 1, 2000, Pages 10-16

  Drew, Allison E ^a   Derbez, Alicia E ^a   Werling, Linda L ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Amphetamine; Epibatidine; Facilitated exchange diffusion; Nicotine; Schizophrenia

Indexed keywords

3 (2 AZETIDINYLMETHOXY)PYRIDINE; ALPHA BUNGAROTOXIN; AMPHETAMINE; CYTISINE; DIHYDRO BETA ERYTHROIDINE; DOPAMINE; DOPAMINE TRANSPORTER; EPIBATIDINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR SENSITIVITY; REGULATORY MECHANISM; SCHIZOPHRENIA; SMOKING;

EID: 0033842918     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2396(200010)38:1<10::AID-SYN2>3.0.CO;2-T     Document Type: Article

References (43)

1. Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine
2. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence form a novel positron emission tomography method
3. Injection of the protein kinase C inhibitor Ro318220 into the nucleus accumbens attenuates the acute response to amphetamine: Tissue and behavioral studies
4. 3H]-dopamine release
5. Protein kinase C activators decrease dopamine uptake into strital synaptosomes
6. Protein kinase C modulates the activity of a cloned gamma-aminobutyric acid transporter expressed in Xenopus oocytes via regulated subcellular redistribution of the transporter
7. 3H]dopamine release by N-substituted nicotine analogies: A new class of nicotinic antagonist
8. Smoking, smoking withdrawal and schizophrenia: Case reports and a review of the literature
9. Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings
10. Dopamine in schizophrenia: A review and reconceptualization
11. Changes in the serotonin(2A) and GABA(A) receptors in schizophrenia: Studies on the human dorsolateral prefrontal cortex
12. Upregulation of surface α4β2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine
13. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4β2 subunits and is upregulated by chronic nicotine treatment
14. Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways
15. 3H]dopamine release from synaptosomes prepared from mouse striatum
16. 3H]dopamine release from mouse striatal synaptosomes in response to chronic L-nicotine treatment
17. Sustained nicotine exposure differentially affects α3β2 and α4β2 neuronal nicotinic receptors expressed in xenopus oocytes
18. Modulation of dopamine transporter activity by nicotinic acetylcholine receptors and membrane depolarization in rat pheochromocytoma (PC12) cells
19. R(+)-8-OHDPAT, a 5-HT(1a) receptor agonist, inhibits amphetamine-indiced dopamine release in rat striatum and nucleus accumbens
20. 2 agonists and antagonists
21. Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striated slices
22. α-Conotoxin MII blocks nicotine-stimulated dopamine release in rat striated synaptosomes
23. Nicotinic receptor function in schizophrenia
24. Nicotine-haloperidol interactions and cognitive performance in schizophrenics
25. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors
26. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits
27. D2 receptors may modulate the function of the striated transporter for dopamine: Kinetic evidence from studies in vitro and in vivo
28. Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat
29. Partial agonist properties of cytisine on neuronal nicotinic receptors containing the β2 subunit
30. Neuronal nicotinic receptor β2 and β4 subunits confer large differences in agonist binding affinity
31. Exclusion of close linkage of the dopamine transporter gene with schizophrenia
32. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine
33. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter
34. Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine
35. Stereoselective nicotine-induced release of dopamine from striated synaptosomes: Concentration dependence andrepetitive stimulation
36. The recombinant GABA transporter GAT1 is downregulated upon activation of protein kinase C
37. Neuronal bungarotoxin blocks the nicotinic stimulation of endogenous dopamine release from rat striatum
38. 3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs
39. 3H]dopamine uptake
40. 3H]dopamine release from rat pheochromocytoma (PC12) cells by sigma-2 receptors
41. Effect of nicotine on dopamine uptake in cos cells possessing the rat dopamine transporter and in PC12 cells
42. Distribution of three nicotinic receptor alpha4 mRNA transcripts in rat brain: Selective regulation by nicotine administration
43. Nicotine increases plasminogen activator protein-1 production by human brain endothelial cells via protein kinase C-associated pathway